TAVALISSE (fostamatinib disodium hexahydrate) Approved by FDA, Available for Order at Biologics by McKesson
CARY, N.C. (May 29, 2018) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, announced […]
ERLEADA™ (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics by McKesson
Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, has been selected by the Janssen Pharmaceutical Companies of Johnson & Johnson…
Biologics, Inc. Joins MedImpact Direct Specialty Program’s Specialty Pharmacy Network: Innovative Hub Conducts Prescription-Level Utilization Management
CARY, N.C. (January 17, 2018) —Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, is […]